Worth Venture Partners’s Gossamer Bio GOSS Stock Holding History

Worth Venture Partners’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.12M	Buy	+312,724	New	+$6.98M	9.29%	3

Other funds holding GOSS

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DIG

DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Worth Venture Partners's GOSS Position: Q2 2026 in Review

Worth Venture Partners opened a new position in Gossamer Bio (GOSS) in Q2 2026: 312,724 shares worth $4.12M. The stake represents 9.29% of the portfolio and ranks #3 among its holdings.

166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

Worth Venture Partners held 312,724 shares of Gossamer Bio worth $4.12M as of Q2 2026.
Gossamer Bio was a new Worth Venture Partners position in Q2 2026.
Gossamer Bio made up 9.29% of Worth Venture Partners's portfolio in Q2 2026, its #3 holding.
166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Worth Venture Partners's 13F filing for Q2 2026, filed 10 Aug 2026.